<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30214288</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Electronic-eCollection">            <Journal>                <ISSN IssnType="Print">1179-1322</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>10</Volume>                    <PubDate>                        <Year>2018</Year>                    </PubDate>                </JournalIssue>                <Title>Cancer management and research</Title>                <ISOAbbreviation>Cancer Manag Res</ISOAbbreviation>            </Journal>            <ArticleTitle>Incidence of bone metastasis and factors contributing to its development and prognosis in newly diagnosed renal cell carcinoma: a population-based study.</ArticleTitle>            <Pagination>                <MedlinePgn>2935-2944</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.2147/CMAR.S170083</ELocationID>            <Abstract>                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">The purpose of this study was to assess the incidence of and the risk factors and prognostic factors for bone metastasis (BM) in initial metastatic renal cell carcinoma (RCC) based on a large population analysis.</AbstractText>                <AbstractText Label="Patients and methods" NlmCategory="UNASSIGNED">Data were obtained for a total of 45,824 RCC patients recorded in the database of the Surveillance, Epidemiology, and End Results program of the National Cancer Institute between 2010 and 2014. Multivariate logistic and Cox regression analyses were used to identify the risk factors and prognostic factors associated with BM in RCC patients. Kaplan-Meier analysis was used to estimate the overall survival of RCC patients, and the difference between the survival curves was tested by log-rank tests.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 1,509 (3.29%) patients were diagnosed with bone metastases at initial diagnosis. Male gender, higher T stage, lymph node involvement, poor tumor grade, presence of lung, liver, and brain metastases, and the collecting duct type of RCC were positively associated with BM occurrence. The median survival time for RCC patients with bone metastases was 12.0 (95% confidence interval [CI]: 10.69-13.31) months, and the survival time for those with collecting duct, clear-cell, papillary, and chromophobe subtypes of RCC were 3 (95% CI: 0.23-5.77), 13 (95% CI: 11.60-14.40), 8 (95% CI: 5.09-10.91), and 11 (95% CI: 5.02-16.98) months; these differences were significantly different (<i>P</i>&lt;0.01). Older age, higher T stage, lymph node involvement, poor tumor grade, the presence of lung, liver, and brain metastases, collecting duct RCC, and the absence of surgical treatments were the factors associated with worse prognoses.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">BM was highly prevalent and significantly decreased the survival rate of RCC patients. A number of factors associated with the development and prognosis of BM were identified, and these insights provide preventive guidelines for screening and treatment of BM in RCC patients.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Guo</LastName>                    <ForeName>Qi</ForeName>                    <Initials>Q</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China, wangguowen@tmu.edu.cn.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Orthopedics, General Hospital of North China Petroleum Administration, Renqiu, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Chao</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China, wangguowen@tmu.edu.cn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Guo</LastName>                    <ForeName>Xu</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China, wangguowen@tmu.edu.cn.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Orthopedics, Cangzhou Central Hospital, Cangzhou, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tao</LastName>                    <ForeName>Fang</ForeName>                    <Initials>F</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China, wangguowen@tmu.edu.cn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>Yao</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China, wangguowen@tmu.edu.cn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Feng</LastName>                    <ForeName>Guowei</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Urology, Tianjin Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Han</LastName>                    <ForeName>Xiuxin</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China, wangguowen@tmu.edu.cn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ren</LastName>                    <ForeName>Zhiwu</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China, wangguowen@tmu.edu.cn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Hui</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopedics, General Hospital of North China Petroleum Administration, Renqiu, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Pingfang</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Orthopedics, General Hospital of North China Petroleum Administration, Renqiu, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Xin</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing 400038, China, wangxinmarine@126.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Guowen</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China, wangguowen@tmu.edu.cn.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>28</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>New Zealand</Country>            <MedlineTA>Cancer Manag Res</MedlineTA>            <NlmUniqueID>101512700</NlmUniqueID>            <ISSNLinking>1179-1322</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2015 May;67(5):913-24</RefSource>                <PMID Version="1">25616710</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urology. 1981 Dec;18(6):556-61</RefSource>                <PMID Version="1">7314355</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Urol Clin North Am. 1994 Nov;21(4):601-24</RefSource>                <PMID Version="1">7974893</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Med Surg (Lond). 2018 Jan 31;27:9-16</RefSource>                <PMID Version="1">29511536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Diagn Res. 2016 Nov;10(11):XD01-XD02</RefSource>                <PMID Version="1">28050490</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1997 Sep 1;80(5):987-9</RefSource>                <PMID Version="1">9307203</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Orthop Sci. 2017 Sep;22(5):924-930</RefSource>                <PMID Version="1">28784566</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Oncol. 2001 Aug;19(2):379-82</RefSource>                <PMID Version="1">11445855</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2015 Feb 05;34:10</RefSource>                <PMID Version="1">25651794</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Assoc Genet Technol. 2018;44(1):5-9</RefSource>                <PMID Version="1">29550805</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2009 Dec;182(6):2595-9</RefSource>                <PMID Version="1">19836761</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2006 Jul;176(1):40-3; discussion 43</RefSource>                <PMID Version="1">16753362</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Cancer. 2008 Nov;44(16):2485-95</RefSource>                <PMID Version="1">18783939</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Urol. 2011 May;185(5):1611-4</RefSource>                <PMID Version="1">21419440</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur Urol. 2007 Oct;52(4):1140-5</RefSource>                <PMID Version="1">17336449</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Compr Canc Netw. 2017 Jun;15(6):804-834</RefSource>                <PMID Version="1">28596261</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">SEER</Keyword>            <Keyword MajorTopicYN="N">bone metastases</Keyword>            <Keyword MajorTopicYN="N">initial renal cell carcinoma</Keyword>            <Keyword MajorTopicYN="N">prognostic factor</Keyword>            <Keyword MajorTopicYN="N">risk factor</Keyword>        </KeywordList>        <CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>15</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30214288</ArticleId>            <ArticleId IdType="doi">10.2147/CMAR.S170083</ArticleId>            <ArticleId IdType="pii">cmar-10-2935</ArticleId>            <ArticleId IdType="pmc">PMC6118275</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>